鷹瞳科技-B：2023年年度報告

Futu NewsApr 25 04:38 ET · Announcements

Eagle Hitomi Technology-B subsidiary plans to invest in partnership with Wenzhou Lufeng and Minsheng Equity Fund

Eagle Hitomi Technology-B (02251) announced that on April 16, 2024, Shanghai Zhongyou (a wholly-owned subsidiary of the company) signed a partnership agreement with Wenzhou Lufeng and Minsheng Equity Fund to establish a partnership. The total capital pledged by all partners under the partnership agreement is RMB 500 million, of which Shanghai Zhongyou promised to invest RMB 250 million. According to reports, the name of the partnership is Wenzhou Luming Private Equity Fund Management Partnership (Limited Partnership). Partnerships should make equity or other forms of investment permitted by applicable law, mainly for life sciences, healthcare services, smart healthcare, and artificial intelligence

新浪港股Apr 16 20:30 ET

Eagle Hitomi Technology-B (02251.HK) signs partnership agreement with Wenzhou Lufeng and Minsheng Equity Fund

Gelonghui, April 16, 丨 Eagle Eye Technology-B (02251.HK) announced that on April 16, 2024, Shanghai Zhongyou (a wholly-owned subsidiary of the company) signed a partnership agreement with Wenzhou Lufeng and Minsheng Equity Fund to establish a partnership. The total capital pledged by all partners under the partnership agreement is RMB 500 million, of which Shanghai Zhongyou promised to invest RMB 250 million. Partnerships shall make equity or other forms of investment permitted by applicable law, mainly in the fields of life sciences, healthcare services, smart medicine, and artificial intelligence. Since the company focuses on using artificial intelligence technology, it is slow

Gelonghui FinanceApr 16 08:48 ET

At a Glance | Airdoc (02251.HK) 2023 Annual Results

On March 27, 2023, Airdoc (2251.HK) announced its 2023 annual results.The company's revenue increased by 79.5% year-on-year, and gross profit increased by 124% year-on-year, achieving both revenue and

Gelonghui FinanceApr 1 05:03 ET

Eagle Hitomi Technology (2251.HK): Commercialization accelerates, AI medical imaging leader will reach an inflection point in performance

Technology is changing the world, and the application of AI technology may accelerate the arrival of the grand vision of “changing the world.” Recently, the “Godfather of AI” Hwang In-hoon declared in various public forums that “AI+ medical systems/biology” is the next shocking revolution to be ushered in in the field of technology. “The future of life science will be as highly engineered as traditional industries. When data science, artificial intelligence, and automation are combined, biology will improve exponentially, making it the next golden track.” This statement not only set off a boom in artificial intelligence and AI medicine in the capital market, but also made investors set their sights on those already looking ahead in this field

Gelonghui FinanceApr 1 01:41 ET

Understand the highlights of the 2023 annual results of Eagle Hitomi Technology (2251.HK) in one picture

On March 27, Eagle Eye Technology (2251.HK, Airdoc) announced the 2023 annual results report. Let me take you to understand the specific results in a picture.

Gelonghui FinanceMar 28 08:26 ET